stockrowMonte Rosa Therapeutics, Inc. (GLUE) vs Syndax Pharmaceuticals, Inc. (SNDX)
- Monte Rosa Therapeutics, Inc. GLUE 9.28 −0.32%
- Syndax Pharmaceuticals, Inc. SNDX 9.26 −2.94%
Monte Rosa Therapeutics, Inc. and Syndax Pharmaceuticals, Inc. are both Biotechnology companies. Monte Rosa Therapeutics, Inc. and Syndax Pharmaceuticals, Inc. are of similar size ($858.9M and $795.5M). Syndax Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 159.5% against −61.3%. Syndax Pharmaceuticals, Inc. has the higher net margin (−72.4% vs −186.2%) and the lower return on invested capital (−83.4% vs 0.00%). Across the 16 metrics below, Monte Rosa Therapeutics, Inc. leads on 8 and Syndax Pharmaceuticals, Inc. on 8.
Valuation
Profitability
| Metric | GLUE | SNDX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 92.21% | 68.27% |
| Operating margin | (214.46%) | (61.72%) | 0.00% |
| Net margin | (186.24%) | (72.38%) | 0.00% |
| Free cash flow margin | (247.98%) | (61.36%) | 0.00% |
| Return on equity | (35.30%) | (426.43%) | (50.82%) |
| Return on assets | (22.63%) | (33.67%) | (46.08%) |
| Return on invested capital | 0.00% | (83.42%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack